Managing Tardive Dyskinesia: New Data from Phase 3 Study of

Check out new data from phase 3 study of Ingrezza for the real-world management of tardive dyskinesia.

Related Keywords

Eiryw Roberts , Neurocrine Biosciences , Goodideas Adobestock , Neurocrine Bioscience , Abnormal Involuntary Movement Scale , Drug Administration , Health Psychol Res , Patient Global Impression , Clinical Global Impression , Ingrezza Sprinkle , Health Psychol ,